631-640 of 840 results for 'consumer data right'

Ugg of war over sheepskin boots in the US
Insight 29 Jun 2021

An appellate court in the US has ruled that the word 'UGG' is capable of trade mark registration in the US for footwear because it is not a generic term – at least in the US – to describe what Australians would call 'ugg boots'. ...

InIP: What's happening in intellectual property - November 2023
Insight 03 Nov 2023

Your regular wrap-up of some of the world's leading and intriguing IP stories. ...

National Electricity and Gas rules update: October 2024
Insight 13 Nov 2024

In our latest update, we examine the progress of new and existing rule change requests to the AEMC across the month of October, as well as take a closer look at how the AEMC is exploring smarter data options for consumers. ...

Priority window closes soon for .au direct domain names
Insight 25 Aug 2022

Further to our last update, the window for existing holders of .au domain names (eg .com.au or .net.au) to claim priority status to register matching .au direct names (eg 'allens.au' instead of 'allens.com.au') closes on 20 September 2022. ...

AI-generated inventions remain unpatentable in Australia – for now
Insight 21 Dec 2022

The High Court has decided not to weigh in on the novel issue of whether patent protection is available for AI-generated inventions. ...

New 12th edition Nice Classification comes into force 1 January 2023
Insight 21 Dec 2022

The World Intellectual Property Organization (WIPO) has announced that the 12th edition of the Nice Classification – the international system for classifying goods and services for registering trade marks – will come into force in the new year, on 1 January 2023. ...

Important developments for offshore diagnostic testing
Insight 01 Sep 2021

In Ariosa Diagnostics, Inc & Ors v Sequenom, Inc [2021] FCAFC 101, the Full Federal Court delivered significant clarity for companies who provide or conduct diagnostic tests. ...

Down-scheduling CBD and growing Australia's cannabis industry
Insight 09 Nov 2020

The Therapeutics Goods Administration is proposing amendments to the Poisons Standard to permit pharmacists to sell low-dose cannabidiol (CBD) products without a prescription. Businesses intending to import, manufacture and supply cannabis products in the Australian market should monitor these developments closely. ...

ASIC consultation on fees and costs disclosure reform following expert review
Insight 18 Mar 2019

Its been a long five years or so of amendments to and consultation on the fees and costs disclosure regime for superannuation and managed investments products And industry might be forgiven for feeling a sense of dj vu with the release earlier this year of ASICs consultation paper on the regime ...

Final report on review of Australia’s patent system
Insight 29 Jun 2021

The Federal Government has released the final report on the review of the accessibility of patents for small and medium sized enterprises (SMEs), which follows the phasing-out of the innovation patent system in Australia. ...

Refine